Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines.

by Elaine Langenfeld, Charles C Hong, Gandhi Lanke, John Langenfeld
Published 2013-01-01

Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis...

by Rachel NeMoyer, Arindam Mondal, Mehul Vora, Elaine Langenfeld, Danea Glover, Michael Scott, Lauren Lairson, Christopher Rongo, David J. Augeri, Youyi Peng, Salma K. Jabbour, John Langenfeld
Published 2019-11-01

Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells

by Arindam Mondal, Rachel NeMoyer, Mehul Vora, Logan Napoli, Zoya Syed, Elaine Langenfeld, Dongxuan Jia, Youyi Peng, John Gilleran, Jacques Roberge, Christopher Rongo, Salma K. Jabbour, John Langenfeld
Published 2021-09-01

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution

by Nikhil Yegya-Raman, MD, Joseph Aisner, MD, Sinae Kim, PhD, Mutlay Sayan, MD, Diana Li, BA, John Langenfeld, MD, Malini Patel, MD, Jyoti Malhotra, MD, MPH, Salma K. Jabbour, MD
Published 2019-07-01